This Deep Dive isn’t about testing red light therapy in a lab, it’s about testing the information environment. A 2025 study analyzed how at-home red light therapy devices are promoted on Instagram and TikTok, and whether social media claims match what dermatology evidence can actually support. Using fresh accounts to reduce algorithm bias, researchers reviewed 132 posts with a combined potential reach of 47.5 million followers. Most content came from non-credentialed creators, and even when posts referenced “studies,” only a small fraction provided actual peer-reviewed citations. The takeaway: photobiomodulation is real — but online marketing often collapses dose-dependent biology into a shopping link, leaving consumers with overpromised outcomes and under-specified protocols.

(Educational content only, not medical advice.)

Article Discussed in Episode:

At-Home Red Light Therapy Devices: Promotion and Recommendation Patterns on Social Media in the Context of Limited Evidence

Key Quotes From Dr. Mike:

“This paper isn’t testing red light therapy—it’s testing the information environment.”

“Social media collapses all the nuance into a shopping link.”

“Most posts said ‘research says’—but almost none showed the papers.”

“The FDA label gets used like an efficacy stamp when it often isn’t.”

“If the recommendation doesn’t include a real protocol, it’s not education — it’s marketing.”

“This isn’t anti-red light therapy. It’s anti-confident misinformation.”

Key points

Study analyzed 132 posts (75 IG, 57 TikTok) from late Jun–mid Jul 2025; potential reach 47.5M.
64.4% of posts came from non-credentialed accounts; physicians made 18.2%.
Physician posts were fewer but carried 38.9% of total follower reach.
TikTok skewed heavily non-credentialed (~87.7%), Instagram more mixed.
Most recommended devices were Red + NIR (63.7%); multi-wavelength next (23.4%); red-only rare (~1.6%).
Social media often treats wavelength as proof—but dose, irradiance, distance, time, and frequency drive outcomes.
Prices ranged $7 to $159,500; median prices differed by credential group (non-credentialed lowest, licensed highest).
Multi-wavelength “more is better” marketing can dilute effective output per band and doesn’t guarantee additive benefit.
Skin benefits dominated (~88.6% of posts), but non-credentialed posts made much broader systemic claims.
Many posts “referenced research,” but only 8.3% provided peer-reviewed journal articles.
“FDA-cleared” is often misread as “FDA-proven effective”—clearance frequently signals safety/low risk, not efficacy for every claim.
Clinician role: set expectations, clarify evidence tiers, teach dosing basics, and avoid amplifying commercial hype.

Episode timeline

0:19–1:55 — Premise: social media claims vs limited evidence; why this matters now.
1:55–3:20 — Methods: new accounts, search terms, timeframe, 132 posts, 47.5M reach.
3:20–5:20 — Credentials + influence: most non-credentialed; physicians smaller share but outsized reach; platform differences.
5:20–8:57 — Devices + pricing: red+NIR dominance; multi-wavelength trend; huge price range; “more wavelengths” myth.
9:00–11:56 — Claims: skin dominates; physicians narrower dermatology claims; non-credentialed expands into systemic promises.
10:50–12:51 — Evidence quality: only 8.3% cite peer-reviewed papers; mismatch between cited studies and marketed devices/protocols.
11:59–12:40 — FDA nuance: clearance ≠ proven efficacy for every claim.
12:53–16:40 — The modern pipeline: discovery → trust proxies → purchase → confusion → clinic.
16:40–18:28 — Consumer/clinician takeaways: demand protocols, set expectations, choose precision over hype.

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

Stay up-to-date on social media:

Dr. Mike Belkowski:

BioLight: